Accuracy in equianalgesic dosing: Conversion dilemmas

被引:146
作者
Anderson, R
Saiers, JH
Abram, S
Schlicht, C
机构
[1] Vet Affairs Med Ctr, Hematol Oncol Serv 111H, Dept Pharm, Albuquerque, NM 87108 USA
[2] Vet Affairs Med Ctr, Med Serv, Albuquerque, NM 87108 USA
[3] Vet Affairs Med Ctr, Dept Anesthesiol, Albuquerque, NM 87108 USA
[4] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Sch Pharm, Albuquerque, NM 87131 USA
关键词
equianalgesic dosing; opioids; chronic pain; palliative care; opioid rotation;
D O I
10.1016/S0885-3924(01)00271-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The clinical benefit and increased application of opioid rotation has focused attention ob efficacy differences opioids and their respective equianalgesic dose rations. Understanding the differences between the opioids is critical to understanding their equianalgesis dose ratios and for adjusting therapy following rotation potencies of these agents as presented in current equianalgesic charts and to provide pharmacologic information to assist the clinician with opioid rotation. (C) U.S. Cancer Pain relief Committee, 2001.
引用
收藏
页码:397 / 406
页数:10
相关论文
共 62 条
[21]   PAIN RELIEF INTO PRACTICE - RHETORIC WITHOUT REFORM [J].
FOLEY, KM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) :2149-2151
[22]   THE TREATMENT OF CANCER PAIN [J].
FOLEY, KM .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (02) :84-95
[23]   Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain [J].
Gagnon, B ;
Bruera, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (02) :120-125
[24]  
Gordon D B, 1999, J Palliat Med, V2, P209, DOI 10.1089/jpm.1999.2.209
[25]  
Gorman AL, 1997, NEUROSCI LETT, V223, P5
[26]   Methadone: Outpatient titration and monitoring strategies in cancer patients [J].
Hagen, NA ;
Wasylenko, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (05) :369-375
[27]  
Hagen NA, 1997, CANCER-AM CANCER SOC, V79, P1428
[28]   Controlled-release oxycodone and morphine in cancer related pain [J].
Heiskanen, T ;
Kalso, E .
PAIN, 1997, 73 (01) :37-45
[29]   A comparison of subcutaneous morphine and fentanyl in hospice cancer patients [J].
Hunt, R ;
Fazekas, B ;
Thorne, D ;
Brooksbank, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (02) :111-119
[30]  
INTURRISI CE, 1989, CANCER, V63, P2308, DOI 10.1002/1097-0142(19890601)63:11<2308::AID-CNCR2820631141>3.0.CO